A New FDA-Approved Antibody May Slow Down Alzheimer’s but Side Effects Are Overwhelming
| | Medicine | No Comments
An FDA-approved antibody called lecanemab can slow down cognitive decline. Scientists say that this drug can have this effect in patients with early stages of Alzheimer’s disease. This gives many patients and their families hope for recovery. But the side effects include bleeding and swelling in the brain. Other patients experience serious brain injuries. Even so, the makers of lecanemab there are side effects that you must be aware of.
To learn more about this article, visit here:
